External quality assessment scheme 2011 for Neisseria meningitidis
Neisseria meningitidis is the major cause of meningitis and rapidly fatal sepsis in healthy individuals worldwide and in Europe, 3 814 (0.75 per 100 000) cases were reported to ECDC in 2011. Meningococcal surveillance systems are partially based on laboratory diagnoses and therefore there is a need for accuracy and proficiency in surveillance laboratory performance. External Quality Assessment (EQA) schemes enable laboratory performance to be assessed against reference methods and compared to other peer laboratories.
This latest report on EQA performance shows that European Reference Laboratories for Meningococci differ in their capacities and the level of characterisation of the distributed N. meningitidis material, but that there have been improvements since the first ECDC IBD-labnet distribution.
The results of the IBD-labnet EQA exercise prove that a regular EQA scheme for the reference laboratories is required in continue to improve the quality of epidemiological reports. It also concludes that targeted training and support might be requested to assist laboratories that have problems with organism characterisation. This is necessary if all EU countries are to provide accurate molecular typing data to TESSy in order to ensure representative European epidemiology of this important disease.
ECDC Evidence Brief: Pre-exposure prophylaxis for HIV prevention in Europe and Central Asia
28 Nov 2019 - This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected in 2018 and 2019 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration. The monitoring questionnaire was disseminated to the 53 countries that are part of the WHO European Region, plus Kosovo and Liechtenstein via an online survey.
HIV testing, Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2018 progress report
27 Nov 2019 - This report presents the situation of HIV testing in Europe and Central Asia. It summarises data on implementation of national guidelines that shape HIV testing policies, the provision and uptake of HIV testing services in general and among key populations, and efforts being made to widen engagement with HIV testing and reduce late diagnosis.
External quality assessment of laboratory performance – European Antimicrobial Resistance Surveillance Network (EARS-Net), 2018
22 Nov 2019 - This report provides an analysis of the external quality assessment (EQA) performance with antimicrobial susceptibility testing (AST) of laboratories participating in the European Antimicrobial Resistance Surveillance Network in 2018. A total of 860 laboratories (1 – 114 per country) from 30 EU/EEA countries participated in the EQA exercise. Six bacterial strains were used: Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, Enterococcus faecium and Streptococcus pneumoniae.